Vitamin D in rheumatoid arthritis

Autoimmunity Reviews

Volumn 7, Issue 1, 2007, Pages 59-64

  Cutolo, Maurizio ^a   Otsa, Kati ^b   Uprus, Maria ^b   Paolino, Sabrina ^a   Seriolo, Bruno ^a  

^a Clinical Academic Unit of Rheumatology   (Italy)

^b East Tallinn Central Hospital Laboratory   (Estonia)

Author keywords

1,25(OH)2D3; Autoimmunity; Rheumatoid arthritis; Sunlight; Vitamin D

Indexed keywords

COLECALCIFEROL; VITAMIN D RECEPTOR;

ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CIRCANNUAL RHYTHM; DENDRITIC CELL; DISEASE ACTIVITY; HORMONE DETERMINATION; HUMAN; IMMUNOREGULATION; MONONUCLEAR CELL; NUTRITIONAL STATUS; PREVALENCE; PROTEIN POLYMORPHISM; REVIEW; RHEUMATOID ARTHRITIS; RISK; SUNLIGHT; T LYMPHOCYTE ACTIVATION; TH1 CELL; ULTRAVIOLET B RADIATION; VITAMIN BLOOD LEVEL; VITAMIN INTAKE;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CYTOKINES; HUMANS; RECEPTORS, CALCITRIOL; VITAMIN D;

EID: 35448965612     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2007.07.001     Document Type: Review

References (40)

1. Holick M.F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 6 (2004) 1678S-1688S
2. Arnson Y., Amital H., and Shoenfeld Y. Vitamin D and autoimmunity: new etiological and therapeutical considerations. Ann Rheum Dis 66 (2007) 1137-1142
3. Fritsche J., Mondal K., Ehrnsperger A., et al. Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha 25-dihydroxyvitamin D3 by human dendritic cells. Blood 102 (2003) 3314-3316
4. Deluca H.F., and Cantorna M.T. Vitamin D: its role and uses in immunology. FASEB J 15 (2001) 2579-2585
5. Langub M.C., Reinhardt T.A., Horst R.L., et al. Characterization of vitamin D receptor immunoreactivity in human bone cells. Bone 27 (2000) 383-387
6. Mahon B.D., Wittke A., Weaver V., et al. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 89 (2003) 922-932
7. Bhalla A.K., Amento E.P., Serog B., et al. 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol 133 (1984) 1748-1754
8. Lemire J.M. Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem 49 (1992) 26-31
9. Mattner F., Smiroldo S., Galbiati F., et al. Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3). Eur J Immunol 30 (2000) 498-508
10. Boonstra A., Barrat F.J., Crain C., et al. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 167 (2001) 4974-4980
11. van E.E., and Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 97 (2005) 93-101
12. Cantorna M.T., Woodward W.D., Hayes C.E., et al. 1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. J Immunol 160 (1998) 5314-5319
13. Staeva-Vieira T.P., and Freedman L.P. 1,25-dihydroxyvitamin D3 inhibits IFNgamma and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. J Immunol 168 (2002) 1181-1189
14. Xue M.L., Zhu H., Thakur A., et al. 1 alpha,25-Dihydroxyvitamin D3 inhibits pro inflammatory cytokine and chemokine expression in human corneal epithelial cells colonized with Pseudomonas aeruginosa 5. Immunol Cell Biol 80 (2002) 340-345
15. Stockinger B. Th17 cells: an orphan with influence 4. Immunol Cell Biol 85 (2007) 83-84
16. Linker-Israeli M., Elstner E., Klinenberg J.R., et al. Vitamin D(3) and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC. Clin Immunol 99 (2001) 82-93
17. Griffin M.D., Lutz W., Phan V.A., et al. Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci U S A 98 (2001) 6800-6805
18. Berer A., Stockl J., Majdic O., et al. 1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol 28 (2000) 575-583
19. Penna G., and Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164 (2000) 2405-2411
20. Griffin M.D., Lutz W.H., Phan V.A., et al. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun 270 (2000) 701-708
21. Helming L., Bose J., Ehrchen J., et al. 1alpha,25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation. Blood 106 (2005) 4351-4358
22. Munger K.L., Zhang S.M., O'Reilly E., Hernán M.A., Olek M.J., Willett W.C., and Ascherio A. Vitamin D intake and incidence of multiple sclerosis. Neurology 62 (2004) 60-65
23. Merlino L.A., Curtis J., Mikuls T.R., et al. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 50 (2004) 72-77
24. Cantorna M.T., Hayes C.E., and DeLuca H.F. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA 93 (1996) 7861-7864
25. Cantorna M.T., Munsick C., Bemiss C., et al. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 130 (2000) 2648-2652
26. Cantorna M.T., and Mahon B.D. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 229 (2004) 1136-1142
27. Sokka T. Rheumatoid arthritis data bases in Finland. Clin Exp Rheumatol 23 Suppl 39 (2005) S201-S204
28. Oelzner P., Muller A., Deschner F., et al. Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 62 (1998) 193-198
29. Nielen M.M., van Schaardenburg D., Lems W., et al. Vitamin D deficiency does not increase the risk of rheumatoid arthritis: comment on the article by Merlino et al. Arthritis Rheum 54 (2006) 3719-19202
30. Cutolo M., Otsa K., Laas K., et al. Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol 24 (2006) 702-704
31. Cutolo M., Otsa K., Yprus M., et al. Vitamin D and rheumatoid arthritis: comment on the letter by Nielen et al. Arthritis Rheum 56 (2007) 1719-1720
32. Andjelkovic Z., Vojinovic J., Pejnovic N., et al. Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. Clin Exp Rheumatol 17 (1999) 453-456
33. Kauppinen-Makelin R., Tahtela R., Loyttyniemi E., et al. A high prevalence of hypovitaminosis D in Finnish medical in-and outpatients. J Intern Med 249 (2001) 559-563
34. Ponsonby A.L., Lucas R.M., and van der Mei I.A. UVR, vitamin D and three autoimmune diseases, multiple sclerosis, type 1 diabetes, rheumatoid arthritis. Photochem Photobiol 81 (2005) 1267-1275
35. Cutolo M. Solar light effects on onset/relapses and circannual/circadian symptomatology in rheumatoid arthritis. Clin Exp Rheumatol 2 (2003) 148-150
36. Rejnmark L., Jorgensen M.E., Pedersen M.B., et al. Vitamin D insufficiency in Greenlanders on a westernized fare: ethnic differences in calcitropic hormones between Greenlanders and Danes. Calcif Tissue Int 74 (2004) 255-263
37. Kamen D.L., Cooper G.S., Bouali H., et al. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 5 (2006) 114-117
38. Garcia-Lozano J.R., Gonzalez-Escribano M.F., Valenzuela A., et al. Association of vitamin D receptor genotypes with early onset rheumatoid arthritis. Eur J Immunogenet 28 (2001) 89-93
39. Maalej A., Petit-Teixeira E., Michou L., et al. Association study of VDR gene with rheumatoid arthritis in the French population. Genes Immun 6 (2005) 707-711
40. Chatfield S.M., Brand C., Ebeling P.R., et al. Vitamin D deficiency in general medical in patients in summer and winter. Intern Med J 37 (2007) 377-382